Sleep Review
  • Disorders
    • Breathing Disorders
    • Insomnia
    • Hypersomnias
    • Movement Disorders
    • Circadian Rhythm Disorders
    • Parasomnias
  • Diagnostics
    • Screeners
    • In-Lab Tests
    • Home Based/Out of Lab
    • Connected Care
    • Consumer Sleep Tracking
  • Treatments
    • Therapy Devices
    • Pharmaceuticals
    • Surgeries & Procedures
    • Behavioral Sleep Medicine
  • Health
    • Parameters
    • Demographics
    • Sleep & Body Systems
    • Prevailing Attitudes
  • Practice Management
    • Money
    • Laws & Regulations
    • Marketing
    • Human Resources
  • Earn CEC
  • Resources
    • Podcasts
    • Webinars
    • White Papers
    • Videos
  • Digital Edition

Select Page

Tag: Dopamine Agonists

All

Latest
Can Dopamine Agonists Blunt Parkinson’s Disease Risk Newly Linked with RLS?

Can Dopamine Agonists Blunt Parkinson’s Disease Risk Newly Linked with RLS?

Both RLS and Parkinson’s disease are associated with dysfunction in the brain’s dopaminergic system, but their causal relationship has remained unclear.

  • Treatment for Parkinson’s Disease and Restless Leg Syndrome Is Linked with Risky Behavior – Here’s What You Need to Know

  • Restless Legs Syndrome Is Incurable – Here’s How to Manage the Symptoms

  • An RLS Prescription Revolution May Have Begun

  • New AASM Guidelines Overhaul Restless Legs Syndrome Treatment

  • Objective Data Shows Dopaminergic Drug Enhances Sleep for Parkinson’s Patients

  • How to Reduce Augmentation Risk in Restless Legs Syndrome

All

Latest
Don’t Light the Fuse of Restless Legs Syndrome with Dopamine Agonists

Don’t Light the Fuse of Restless Legs Syndrome with Dopamine Agonists

Twenty percent of restless legs syndrome patients are already on higher-than-recommended doses of dopamine agonists, says John Winkelman, MD, PhD.

  • What Medications Are Linked With Periodic Limb Movements in Sleep?

    What Medications Are Linked With Periodic Limb Movements in Sleep?

  • ‘Dopamine Agonists Should Not Be a First-line Treatment for Restless Legs Syndrome’  

    ‘Dopamine Agonists Should Not Be a First-line Treatment for Restless Legs Syndrome’  

  • Restless Legs Syndrome Research Will Become Easier to Compare & Replicate

    Restless Legs Syndrome Research Will Become Easier to Compare & Replicate

  • Reducing RLS Augmentation: Scientist Identifies a New Pathway to Maintain Restless Legs Syndrome Treatment Efficacy

    Reducing RLS Augmentation: Scientist Identifies a New Pathway to Maintain Restless Legs Syndrome Treatment Efficacy

  • Are Dopamine Agonists Doing More Harm Than Good for Restless Legs Syndrome Patients?

    Are Dopamine Agonists Doing More Harm Than Good for Restless Legs Syndrome Patients?

All

Latest
Sorry, No Posts Found
Sorry, No Posts Found

Sleep Review

7300 W 110th St – Floor 7
Overland Park, KS 66210

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Media Solutions Kit

Press Releases

Key Resources

Digital Edition

Podcasts

Webinars

White Papers

Videos

Helpful Links

Submit a Press Release

Advisory Board

Submit an Article

Subscribe

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2026 MEDQOR LLC. All Rights Reserved

✖